Flu virus shells could improve delivery of mRNA into cells

Nanoengineers at the University of California San Diego have developed a new and potentially more effective way to deliver messenger RNA (mRNA) into cells. Their approach involves packing mRNA inside…

Read More »

Meiosis: Where the Sex Starts – Crash Course Biology #13

Reproduction! Always a popular topic, and one that I don't mind saying that I'm personally interested in. The kind of reproduction that we're most familiar with of course is sexual…

Read More »

The Most Important Concept in Biology (Chapter 1)

The goal is for you to leave this video with an intuitive understanding of one of the most important concepts in all of science: The Central Dogma. This crucial idea…

Read More »

Synthetic tissue can repair hearts, muscles, and vocal cords

Combining knowledge of chemistry, physics, biology, and engineering, scientists from McGill University develop a biomaterial tough enough to repair the heart, muscles, and vocal cords, representing a major advance in…

Read More »

Biosensor barcodes identify, detail ‘chatting’ among cancer cells

Ever since the first barcode appeared on a pack of chewing gum in 1974, the now-ubiquitous system has enabled manufacturers, retailers and consumers to quickly and effectively identify, characterize, locate…

Read More »

New review highlights cancer-crushing viruses

With the world still in the grip of a devastating pandemic, it’s hard to imagine viruses as something other than hostile enemies to be vanquished. But in a recent review…

Read More »

Correcting inherited gene alterations speeds up

Researchers in the University of Helsinki and University Hospital Helsinki have developed a method to precisely and rapidly correct genetic alterations in the cultured patient cells. The method produces genetically…

Read More »

Mei, with Bayer and Gilead in its sights, posts pivotal data on blood cancer prospect

Mei Pharma’s bid to break into a congested market fought over by Bayer and Gilead has yielded data. The pivotal trial linked zandelisib to a 70% response rate in follicular…

Read More »

GlaxoSmithKline poaches Pfizer vax leader Dormitzer after hemorrhaging vaccine R&D talent

GlaxoSmithKline has seen a host of vaccine research staffers exit the Big Pharma over the past year, but it’s hoping a big name can get its vaccine business back on…

Read More »

ImmunoGen lines up FDA filing as antibody-drug conjugate shrinks tumors in pivotal trial

After toiling for 40 years, ImmunoGen can now see the potential approval of its first wholly owned oncology drug on the horizon. The biotech is preparing to submit mirvetuximab soravtansine…

Read More »